The PAM50, gene expression classifier which has been used to group breast cancers into Luminal A, Luminal B, Basal, and Her2-like subsets; the luminal breast cancer subtypes express higher levels of estrogen receptor and progesterone receptor and are more responsive to hormonal therapy [351]. Here, ESR1 is linked to breast cancer.